A comparison of prednisolone with azathioprine and prednisolone with intramuscular gold in rheumatoid arthritis. 1988

H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
Division of Rheumatology, Medical Policlinical Institute, Bereich Medizin Karl-Marx-University, Leipzig, GDR.

Pulse prednisolone hemisuccinate therapy (500 mg given intravenously on three occasions over two weeks) has been combined with either intramuscular sodium aurothiomalate or azathioprine in an assessment of 30 patients with rheumatoid arthritis. Significant improvement in a variety of clinical and biochemical assessments was seen in both groups. Both treatments were well tolerated by the patients and prednisolone appeared to accelerate the response to sodium aurothiomalate and azathioprine but there was no great evidence that it enhanced it.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006052 Gold Sodium Thiomalate A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis. Aurothiomalate,Gold Thiomalate,Sodium Gold Thiomalate,Aurolate,Gold Disodium Thiomalate, Monohydrate,Gold Thiomalic Acid,Mercaptobutanedioic Acid Monogold(1+) Sodium Salt,Miocrin,Miocrisin,Monogold (1+) Disodium Thiomalate,Myochrysine,Myocrisin,Myocrysine,Sodium Aurothiomalate,Sodium Thiomalatoaurate,Tauredon,Aurothiomalate, Sodium,Gold Thiomalate, Sodium,Sodium Thiomalate, Gold,Thiomalate, Gold,Thiomalatoaurate, Sodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
March 1977, Arthritis and rheumatism,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
September 1974, British medical journal,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
June 1977, Comprehensive therapy,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
May 1971, Rheumatology and physical medicine,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
August 2003, The Journal of rheumatology,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
July 1974, Annals of the rheumatic diseases,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
February 1969, British medical journal,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
August 1956, Revista clinica espanola,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
January 1995, Scandinavian journal of rheumatology,
H Häntzschel, and W Otto, and S Arnold, and W Seidel, and W Krüger, and P Winiecki, and H A Bird, and J S Dixon, and G Astbury, and V Wright
October 1982, European journal of clinical pharmacology,
Copied contents to your clipboard!